Cromolyn Disease Interactions
There is 1 disease interaction with cromolyn.
Cromolyn (applies to cromolyn) renal/liver disease
Minor Potential Hazard, Low plausibility. Applicable conditions: Renal Dysfunction
Systemically absorbed cromolyn is eliminated almost equally by renal and biliary routes. Although less than 1% of an orally ingested dose and approximately 8% of an orally inhaled dose is systemically available, the manufacturers recommend that a dosage reduction be considered in patients with impaired renal or hepatic function.
References (7)
- Richards R, Dickson CR, Renwick AG, Lewis RA, Holgate ST (1987) "Absorption and disposition kinetics of cromolyn sodium and the influence of inhalation technique." J Pharmacol Exp Ther, 241, p. 1028-32
- Rosenberg JL, Edlow D, Sneider R (1978) "Liver disease and vasculitis in a patient taking cromolyn." Arch Intern Med, 138, p. 989-91
- Neale MG, Brown K, Hodder RW, Auty RM (1986) "The pharmacokinetics of sodium cromoglycate in man after intravenous and inhalation administration." Br J Clin Pharmacol, 22, p. 373-82
- Fuller RW, Collier JG (1983) "The pharmacokinetic assessment of sodium cromoglycate." J Pharm Pharmacol, 35, p. 289-92
- Walker SR, Evans ME, Richards AJ, Paterson JW (1972) "The fate of [14C]disodium cromoglycate in man." J Pharm Pharmacol, 24, p. 525-31
- (2001) "Product Information. Intal (cromolyn)." Rhone Poulenc Rorer
- (2001) "Product Information. Gastrocrom (cromolyn)." Rhone Poulenc Rorer
Switch to consumer interaction data
Cromolyn drug interactions
There is 1 drug interaction with cromolyn.
Report options
More about cromolyn
- cromolyn consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (30)
- Side effects
- Dosage information
- During pregnancy
- Drug class: mast cell stabilizers
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Xolair
Xolair injection (omalizumab) is used to help improve allergic asthma, nasal polyps, and chronic ...
Prilosec
Prilosec (omeprazole) is used to treat symptoms of GERD and other conditions caused by excess ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Prevacid
Prevacid is used to treat and prevent stomach and intestinal ulcers. Learn about side effects ...
Gleevec
Gleevec is targeted cancer therapy for specific types of leukemia (blood cancer), bone marrow ...
Gastrocrom
Gastrocrom is used for inflammatory bowel disease, systemic mastocytosis
Ayvakit
Ayvakit (avapritinib) is a prescription medicine used for the treatment of gastrointestinal stromal ...
Avapritinib
Avapritinib is used for gastrointestinal stromal tumor, systemic mastocytosis
Midostaurin
Midostaurin is used for acute myeloid leukemia, systemic mastocytosis
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.